Phase III programme for the use of otilimab for rheumatoid arthritis launched
5 July 2019 | By European Pharmaceutical Review
A Phase III clinical development programme testing otilimab in patients with RA has begun.
List view / Grid view
GlaxoSmithKline (GSK)
GSK reported to have started the sale of $1.2 billion consumer health drugs
26 June 2019 | By European Pharmaceutical Review
According to Reuters, GSK has started the sale of some consumer health brands as it seeks to raise £1 billion.
Microbiology In-Depth Focus 2019
7 May 2019 | By European Pharmaceutical Review
The work of a pharmaceutical scientist requires precision, attention to detail and is of vital importance to the safety of products and ultimately patients. This section features insights from experienced scientists who’ve worked extensively in microbiological analysis, developing tests, methods and standards that help establish a foundation for the production…
$100 million is to be invested to increase vaccine manufacturing in US
30 April 2019 | By European Pharmaceutical Review
A $100 million investment has been made to support long-term vaccine manufacturing capabilities in the US.
GSK named one of ‘top companies’ to work for in UK
8 April 2019 | By European Pharmaceutical Review
Some of the key findings show that job seekers are drawn to companies with long histories and large organisations with over 50,000 employees...
Key packaging trends for 2019
21 February 2019 | By Nikki Withers (European Pharmaceutical Review)
Consumer demands, a focus on sustainability and recycling, and political uncertainty in the UK are just a few challenges the packaging market had to overcome last year. Nikki Withers speaks to Ron Yakubison, Director of Pharmaceutical Packaging Operations at Merck Manufacturing and Sriman Banerjee, Head of Packaging at GSK, who…
EMA grants marketing authorisation for subcutaneous formulation of Benlysta against lupus
15 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
The EU has approved a new subcutaneous formulation of Benlysta, as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus...
Experimental Ebola vaccines elicit year-long immune response
13 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year...
Developing OTC syrup packaging for the highly regulated EU market
21 August 2017 | By Piotr Zaborniak
The regulatory environment has a great impact on business, especially in healthcare. Non-compliance exposes companies to the risk of launch delay, delisting products from the market and out-of-stocks. Moreover, it can cause reputational damage affecting staff, consumer and shareholder confidence, reduce market opportunities, and affect the bottom line.
Current trends in freeze-drying
21 August 2017 | By Yves Mayeresse
This article reviews the trends in freeze drying highlighted at recent Parenteral Drug Association (PDA) conferences...
Consortium established to support ICH M7 compliance
31 July 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
An industry work-group comprising of toxicologists, pharmaceutical companies and data experts plans to unveil the early results of a data sharing project...
ViiV Healthcare submits regulatory applications for HIV two-drug regimen
6 June 2017 | By Niamh Marriott, Junior Editor
Regulatory submissions to the EMA and FDA for a single-tablet, two-drug regimen of dolutegravir & rilpivirine for the maintenance treatment of HIV...
Relocating the EMA: An open letter from EFPIA and Pharma Heads of Research
16 May 2017 | By European Federation of Pharmaceutical Industries and Associations (EFPIA)
The EMA is a world class regulator, whose scientific recommendations are a vital element of the ongoing effort to provide EU citizens with quality medicines
First female CEO of GSK to be paid 25% less than her male predecessor
31 March 2017 | By Niamh Marriott, Junior Editor
Emma Walmsley will succeed Andrew Witty as GSK CEO, when he retires on 31 March 2017, making her the first female CEO of a major global pharmaceuticals company.
The top 21… wealthiest pharma companies
6 February 2017 | By Niamh Marriott (European Pharmaceutical Review)
European Pharmaceutical Review has been keeping the industry informed for 21 years and continues to bring insights into current and emerging technologies, contributions from recognised figures in the life science community and of course, the latest and most up to date news. To celebrate our success, we will be counting down…
Follow: